| Study Period | 2019 - 2032 |
| 2024 Market Size | USD 8.3 Billion |
| 2025 Market Size | USD 8.7 Billion |
| 2032 Forecast | USD 13.1 Billion |
| Growth Rate (CAGR) | 5.90% |
| Largest Region | North America |
| Fastest Growing Region | APAC |
| Nature of the Market | Fragmented |
|
Explore the market potential with our data-driven report
The global enteral nutrition market size is USD 8.3 billion in 2024, and it is projected to reach USD 13.1 billion by 2032, growing at a CAGR of 5.9% during 2025–2032. This growth can be attributed to the growing geriatric population, surging number of victims of malnutrition receiving treatment, and lower cost of products.
This is the most preferred way of feeding infants who are vulnerable to disease and death, due to undernutrition and deficiencies in vitamins and minerals. Furthermore, an increase in awareness about the advantages of early enteral feeding, which reduces septic and non-septic complications and improves clinical outcomes of critically ill and injured patients, is expected to boost the market growth over the years.
Moreover, shifting preference from parenteral nutrition to enteral is another major factor driving the market, as it is gaining popularity over the years, owing to the improvement in techniques, compositions, and materials. Parenteral is a less preferred technique due to its higher complication rate and cost. However, parenteral nutrition is preferred only when patients are unable to tolerate enteral procedures. This has shifted the interest of players providing clinical nutrition from parenteral nutrition to enteral, which is also is being preferred for long-term feeding in old age patients, thereby fueling the product demand in the market.
The standard enteral nutrition category holds the larger revenue share in 2024, of 70%. This is primarily driven by the widespread acceptance of regular protein diets, since it is one of the most preferred compositions suggested for patients suffering from diabetes, cancer, and other disorders that make it difficult to consume solid meals. The introduction of typical protein-rich products is meeting the market demand. Furthermore, there has been a significant increase in the need for products derived from organic sources, resulting in the rising demand for conventional protein diets.
The disease-specific category is set to witness the higher CAGR because different diseases cause different nutritional deficiencies. Hence, to maximize the effect of therapy, standard formulae are not viable. Further, with the increasing focus on personalized medicine, enteral nutrition products are being created after studying individual patients’ diseases and genomes.
The following product types are part of the scope:
Protein nutrients hold the largest market share, and they will also grow the fastest, with 6.5% CAGR, during the forecast period. This is due to the increasing consumer awareness regarding balanced diets across the world. The increased demand for protein nutrients is driven by socio-economic changes such as rising disposable income, the aging population, and the recognition of the role of protein in a healthy diet.
Furthermore, economic development and rapid urbanization are leading to major transitions in population-level dietary patterns in emerging countries in particular, such that most of the increased demand for foods of animal origin is seen in developing nations.
Here are the nutrition types considered in the study:
The hospital pharmacies category account for the biggest revenue share, of 55%, in 2024, and it is expected to dominate the market in the coming years as well. This is due to the increased number of inpatients and outpatients in hospitals, as well as patients' preference for hospital pharmacies.
The prices of pharmaceuticals in hospital pharmacies are lower as compared to other distribution channels, and customers are free to negotiate with hospital officials based on their budget. Also, easy access to these pharmacies is a major driver to boosting the sales of pharmaceutical products, thereby driving the growth of the market.
The online pharmacies category is projected to witness the highest CAGR during the forecast period. This can be because the enhanced patient-provider communication and promotional campaigns are projected to increase the online delivery of enteral feeding products for short- and long-term care among critical patients. Also, it provides comfort to patients with the delivery of essentials to their place of stay.
The report includes insights on these distribution channels:
The liquid form category dominates the market, and it is expected to grow at the higher CAGR during the forecast period. The liquid form of these products is a ready-to-use or instant nutrition formula available in prefilled, ready-to-hang containers and specially designed cans for tube feeding. Before being boosted or pierced with a feeding set, these packages can be kept at room temperature. The rapid absorption of the formula by the gastric walls, resulting in a quicker metabolic rate, is one of the significant benefits of taking these products in a liquid form.
We have analyzed the below-mentioned forms:
The adult patients bifurcation dominates the market with 75% share, and it is predicted to grow faster in the coming years. Furthermore, patients with a body mass index of <20 are considered chronically ill and typically suffer from cancer, gastrointestinal diseases, respiratory issues, and neurological or psychiatric disorders. These patients are at high risk for malnutrition, and such factor stimulates the growth of the market in this category. The absorption capacities of the human digestive framework reduce with age, making it difficult for the body to retain all of the needed nutrients from food. Appetite loss is a typical problem among the elderly. As a result, elderly persons do not receive adequate amounts of vitamins. The primary issues among the older population that require nutritional assistance include bone degeneration, poor digestive structure, immobility, and chronic and degenerative disorders. Thus, the senior population is increasingly reliant on nutrition supplements to keep active, which further drives the growth of the enteral nutrition market.
The segment is bifurcated as follow:
Drive strategic growth with comprehensive market analysis
North America hold the largest revenue share, of 45%, in 2024 in the market. This is due to the well-established healthcare industry and the presence of a large number of product manufacturers in the region. Moreover, the increased use of nutritional products and the rise in the number of patients with chronic diseases have boosted the demand for nutrition products in North America.
Furthermore, an increase in the number of patients suffering from gastrointestinal disorders in the U.S. drives the adoption of tube nutrition. For instance, according to the Office of Disease Prevention and Health Promotion report, chronic diseases are the leading cause of death in the U.S., i.e., 7 out of 10 deaths per year.
In addition, Europe accounts for the second-largest share of the market. The increasing aging population, high incidence of cancer, and high birth rates in countries, such as the U.K. and France, are driving the growth of the market in the region.
Geographically, the APAC region is projected to witness the fastest growth in the enteral nutrition market, with 7% CAGR. This is owing to the increase in the population suffering from cancer, neurological disorders, gastrointestinal disorders, diabetes, and other chronic conditions, rise in the geriatric population in emerging economies, development of the R&D sector, rise in healthcare reforms, and technological advancements in enteral nutrition products. Moreover, the surge in the focus of leading manufacturers on expanding their geographical presence in the emerging economies of the region, to capture a large market share, is expected to drive the growth of the enteral nutrition market in APAC.
We studied these regions and countries:
The enteral nutrition market is fragmented as a large number of companies offer these products. Further, although these products are tested for quality before approval, the regulatory criteria is not as strict as for pharmaceuticals. Additionally, different formulations are required for different age groups and indications, and since no company offers everything, the market displays fragmentation. This also allows local and regional companies to compete with globally operating nutrition and pharmaceutical companies. Moreover, since these products are similar to normal food, the entry barriers in this market are not as high. Another reason for the consolidation is that while healthcare facilities generally buy in bulk under long-term contracts with established companies, individuals often prefer local firms, which offer cost-effective products.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages